"I hadn't slept more than three hours straight in six years. Every night was the same — the same faces, the same sounds, waking up drenched in sweat with my heart pounding. Cannabis didn't erase what happened. But it gave me enough quiet to start healing."
— Marcus T., 38, USMC veteran, two combat deployments to Afghanistan
Marcus joined the Marine Corps at 19, motivated by a family tradition of military service and a desire to serve after September 11th. He completed two deployments to Helmand Province, Afghanistan — 2008 and 2011 — seeing sustained combat in some of the most dangerous territory of the war. He returned home physically intact. The psychological damage took years to surface fully.
"The first year back, I thought I was fine. I was busy, I was working, I was moving. It was when things slowed down that it hit me." The nightmares began in 2013. Hypervigilance — the constant scanning of environments for threats, the inability to sit with his back to a door, the startle response to car backfires — became exhausting. He avoided crowds, then social situations, then eventually leaving his apartment.
His VA diagnosis was PTSD with comorbid major depressive disorder. He was prescribed sertraline (Zoloft) and referred to group therapy. "The group therapy helped some. The medication helped some. But the nightmares — nothing touched the nightmares."
Marcus's experience reflects a well-documented gap in PTSD treatment. While Prolonged Exposure (PE) and Cognitive Processing Therapy (CPT) are the gold-standard evidence-based treatments, they require patients to repeatedly confront traumatic memories — a process that many veterans find intolerable. Dropout rates from these therapies can exceed 30%.
Prazosin, an alpha-blocker sometimes prescribed for PTSD nightmares, was tried and discontinued after causing orthostatic hypotension. A second antidepressant trial with venlafaxine produced intolerable side effects. "I felt like I was running out of options. I was 34 years old and I couldn't hold a job, couldn't maintain a relationship, couldn't sleep. I was disappearing."
Marcus was introduced to medical cannabis through a veteran peer support group. Several other veterans in the group had found relief, particularly for sleep and nightmares. He was skeptical — "I'd been told my whole military career that marijuana was a drug of abuse" — but desperation overcame skepticism.
He obtained a medical cannabis card in his state and consulted with a physician experienced in veteran PTSD. The physician explained the science: THC suppresses REM sleep, the sleep stage during which nightmares occur. This is why THC-dominant products, taken before bed, can dramatically reduce nightmare frequency in PTSD patients. CBD, meanwhile, has anxiolytic properties that may reduce daytime hypervigilance.
His initial protocol: 5mg THC in an oral capsule 30 minutes before bed, combined with 20mg CBD sublingual tincture. He was advised to continue his existing therapy and medications, and to track his sleep and nightmare frequency.
"The first night I took it, I slept five hours straight. I hadn't done that in years. I woke up and just sat there, not quite believing it." The nightmares didn't disappear immediately — but their frequency dropped from nightly to two or three times per week within the first month. Their intensity diminished. He began waking from them more quickly, returning to sleep more easily.
Over three months, Marcus's sleep improved steadily. He added a daytime CBD regimen — 15mg sublingual twice daily — which he found reduced his hypervigilance and made social situations more manageable. "I could sit in a restaurant again. I could go to my nephew's baseball game. Small things that had become impossible."
Marcus credits cannabis not as a standalone treatment but as a tool that made other treatments possible. "When I was sleeping, I had the energy and the emotional bandwidth to actually engage with therapy. Before, I was so depleted that I was just going through the motions."
He re-engaged with Cognitive Processing Therapy — the same therapy he had previously found intolerable. With better sleep and reduced baseline anxiety, he was able to complete the full 12-session protocol. "I'm not going to say it was easy. It was the hardest thing I've ever done. But I could do it. Before cannabis, I couldn't."
Marcus now works as a peer support specialist at a veteran services organization, helping other veterans navigate mental health treatment. He continues to use cannabis — a lower dose than initially, as his symptoms have improved. He still takes sertraline. He attends monthly therapy.
"I'm not cured. PTSD doesn't work that way. But I'm functional. I'm present. I have a life." He recently got engaged. He coaches youth football on weekends. He sleeps most nights.
Marcus's experience is consistent with clinical evidence. THC suppresses REM sleep through CB1 receptor activation in the brainstem, reducing nightmare frequency. A 2009 open-label trial by Fraser found that nabilone (synthetic THC) significantly reduced PTSD nightmare frequency and improved sleep quality in combat veterans. A 2014 survey of 80 PTSD patients found cannabis use was associated with a 75% reduction in PTSD symptom severity scores. The Multidisciplinary Association for Psychedelic Studies (MAPS) is currently conducting Phase 3 trials of cannabis for PTSD. However, long-term THC use carries risks including tolerance, dependence, and potential worsening of anxiety in some patients — individual responses vary significantly.